Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0641
D

Inaccurate MDS Documentation of Psychotropic Medication Administration

Cimarron, Kansas Survey Completed on 11-17-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to accurately complete the Minimum Data Set (MDS) for one resident, specifically regarding the documentation of psychotropic medications administered during the assessment lookback period. The resident in question had diagnoses of anxiety, depression, and insomnia, and was prescribed multiple psychotropic medications, including an antipsychotic (Abilify) and a hypnotic (trazodone). However, the MDS assessment did not record the administration of antipsychotic and hypnotic medications, despite evidence from the electronic medical record, care plan, and physician orders that these medications were given during the lookback period. Interviews with facility staff confirmed that the MDS should have indicated the use of antipsychotic and hypnotic medications, but this was not done. The facility's policy requires accuracy, timeliness, and completeness in all MDS assessments, referencing the RAI manual. The deficiency was identified through observation, record review, and staff interviews, which revealed the omission in the MDS documentation for the resident who was receiving several psychotropic medications as part of their treatment plan.

An unhandled error has occurred. Reload 🗙